Neurochem Aktie - NRMX

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Premium

Current Price

2,00

Gebot

0,00

Fragen

0,00

Volumen

0,00 Tagesbereich 0,00

0,00 52-Wochen-Bereich 0,00

Handelsende

2,00

Handelsbeginn

Letzte Trade

Letzter Handelszeitpunkt

Durchschnittliches Volumen (3 Mio.)

Finanzvolumen

VWAP

At Annual and Special Meeting of Shareholders - Neurochem to officially adopt new name - BELLUS Health - And to provide update o

Neurochem Annual and Special Meeting web cast live LAVAL, QC, April 15 /PRNewswire-FirstCall/ -- At the Annual and Special meeting of Neurochem...

Media advisory - Neurochem's Annual and Special Meeting of Shareholders April 15, 2008

LAVAL, QC, April 11 /PRNewswire-FirstCall/ -- Dr. Francesco Bellini, Chairman, President and Chief Executive Officer of Neurochem Inc., invites...

Neurochem Annual and Special Meeting of shareholders

Neurochem will host a live Web conference on Tuesday, April 15, 2008, at 10:00 AM ET LAVAL, QC, April 11 /PRNewswire-FirstCall/ -- Dr. Francesco...

Neurochem moves eprodisate (KIACTA(TM)) drug development program forward for Amyloid A amyloidosis

ECUBLENS, SWITZERLAND, March 13 /PRNewswire-FirstCall/ -- Neurochem (International) Limited (Neurochem), a wholly-owned subsidiary of Neurochem...

Neurochem announces departure of two members of management team

LAVAL, QC, Feb. 21 /PRNewswire-FirstCall/ -- In light of Neurochem Inc.'s (NASDAQ: NRMX; TSX: NRM) new strategic direction, the Company...

Neurochem reports results for fourth quarter and fiscal year 2007 and important advances on corporate objectives

Neurochem will host a conference call Thursday, February 21, 2008, at 8:30 A.M. ET. LAVAL, QC, Feb. 20 /PRNewswire-FirstCall/ -- Neurochem Inc...

/C O R R E C T I O N from source -- Neurochem Inc./

In MO389 sent on Monday February 11 2008 at 10:45e, an error occured in the link to the Web cast in the second paragraph. The correct link should...

Neurochem to present at 2008 BIO CEO & Investor Conference - Presentation will be Web cast live

LAVAL, QC, Feb. 11 /PRNewswire-FirstCall/ -- Neurochem Inc. (NASDAQ: NRMX; TSX: NRM) announces today that on Wednesday, February 13, 2008, Dr...

Neurochem appoints Mr. Gary Schmid as CEO of new nutraceutical business

LAVAL, QC, Jan. 30 /PRNewswire-FirstCall/ -- Neurochem Inc. (NASDAQ: NRMX; TSX: NRM) is pleased to announce that Mr. Gary Schmid will join...

Neurochem to present at JPMorgan Healthcare Conference

LAVAL, QC, Jan. 3 /PRNewswire-FirstCall/ -- Neurochem Inc. (NASDAQ: NRMX; TSX: NRM) announces today that on Thursday, January 10, 2008, Dr...

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

NRMX - Frequently Asked Questions (FAQ)

What is the current Neurochem share price?

The current share price of Neurochem is US$ 2,00

What is the 1 year trading range for Neurochem share price?

Neurochem has traded in the range of US$ 0,00 to US$ 0,00 during the past year

Volumen
% Tops
% Flops

Symbol	Preis	Vol.
STAKSTAK Inc	US$ 3,97 (156,13%)	174,23k
ORGOOrganogenesis Holdings Inc	US$ 6,21 (102,28%)	59M
TRNRInteractive Strength Inc	US$ 2,57 (67,97%)	193,57M
PMAXPowell Max Ltd	US$ 0,511 (43,54%)	137,18M
ARBBARB IOT Group Ltd	US$ 0,6635 (38,23%)	59,08M
NVNINVNI Group Ltd	US$ 0,99 (-50,50%)	72,79M
SPGCSacks Parente Golf Inc	US$ 0,2085 (-48,65%)	58,21M
ADGMAdagio Medical Holdings Inc	US$ 0,8081 (-47,53%)	756,76k
PRAXPraxis Precision Medicines Inc	US$ 38,60 (-40,64%)	3,2M
SAGSAG Holdings Ltd	US$ 1,19 (-38,97%)	789,86k
NVDANVIDIA Corporation	US$ 124,92 (3,97%)	389,48M
TRNRInteractive Strength Inc	US$ 2,57 (67,97%)	193,57M
TSLLDirexion Daily TSLA Bull 2X Trust ETF	US$ 13,44 (7,78%)	154,46M
PMAXPowell Max Ltd	US$ 0,511 (43,54%)	137,18M
LCIDLucid Group Inc	US$ 2,22 (-0,45%)	136,17M

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Neurochem - Common Shares (MM) (NRMX)

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

NRMX Neueste Nachrichten

At Annual and Special Meeting of Shareholders - Neurochem to officially adopt new name - BELLUS Health - And to provide update o

Media advisory - Neurochem's Annual and Special Meeting of Shareholders April 15, 2008

Neurochem Annual and Special Meeting of shareholders

Neurochem moves eprodisate (KIACTA(TM)) drug development program forward for Amyloid A amyloidosis

Neurochem announces departure of two members of management team

Neurochem reports results for fourth quarter and fiscal year 2007 and important advances on corporate objectives

/C O R R E C T I O N from source -- Neurochem Inc./

Neurochem to present at 2008 BIO CEO & Investor Conference - Presentation will be Web cast live

Neurochem appoints Mr. Gary Schmid as CEO of new nutraceutical business

Neurochem to present at JPMorgan Healthcare Conference

NRMX - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Neurochem - Common Shares (MM) (NRMX) Börsenkurse

Neurochem - Common Shares (MM) (NRMX)

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

NRMX Neueste Nachrichten

At Annual and Special Meeting of Shareholders - Neurochem to officially adopt new name - BELLUS Health - And to provide update o

Media advisory - Neurochem's Annual and Special Meeting of Shareholders April 15, 2008

Neurochem Annual and Special Meeting of shareholders

Neurochem moves eprodisate (KIACTA(TM)) drug development program forward for Amyloid A amyloidosis

Neurochem announces departure of two members of management team

Neurochem reports results for fourth quarter and fiscal year 2007 and important advances on corporate objectives

/C O R R E C T I O N from source -- Neurochem Inc./

Neurochem to present at 2008 BIO CEO & Investor Conference - Presentation will be Web cast live

Neurochem appoints Mr. Gary Schmid as CEO of new nutraceutical business

Neurochem to present at JPMorgan Healthcare Conference

NRMX - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Werbung entfernen

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS